Potential pathways were also predicted, including those involved in lipid metabolism, atherosclerosis, PI3K‐Akt signaling, MAPK, IL‐17, TNF, neurotrophin signaling, apoptosis, Alzheimer's disease, and other neurodegenerative diseases. Here, AKT1 is linked to early-onset autosomal dominant Alzheimer disease.